Transforming Healthcare Through
Science and Innovation
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease
Prof. El-Agnaf is considered a pioneer in the field of Parkinson’s disease and related disorders. Several inventions have emerged from his research, and his discoveries have greatly impacted the scientific research community, provided further insight into the molecular pathogenesis of Parkinson’s disease, and offered new opportunities for the development of novel diagnostic and therapeutic tools for Parkinson’s disease. His research has also been translated into clinical studies to evaluate the potential use of α-synuclein in body fluids as diagnostic marker for Parkinson’s disease and related disorders. MORE INFO.
Open Positions
QBRI is currently looking to recruit highly-skilled individuals for a number of roles.
Publications by QBRI Scientists
Qatar Biomedical Research Institute Signs Memorandum of Understanding with the Shafallah Center
08/04/2018
The two partners will work together on research projects related to neurodevelopmental disorders
QBRI Best Arab Research Institution of 2017
28/11/2017
Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), won the prestigious Arab Best Research Institution of the Year 2017 award, confirming the institute's position...
Metabolon to Establish Metabolomics Lab in Qatar to Serve Markets in the Middle East
04/05/2017
Metabolon to Establish Metabolomics Lab in Qatar to Serve Markets in the Middle East
26/10/2016
A group of scientists led by Dr. Abdelilah Arredouani from the Diabetes Research Center at the Qatar Biomedical Research Institute (QBRI), a research institute of Hamad bin Khalifa University (HBKU)...
Why are so many researchers moving to Qatar?
09/06/2016
Elsevier Science recently published an article questioning why so many scientific researchers are choosing to work in Qatar. Prof. Omar El Agnaf, QBRI's new Acting Executive Director, was one of ...
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease
23/05/2017
,
SMALL LECTURE THEATRE, Sherrington Building
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease
The 1st Annual Qatar Metabolic Institute Conference
30/04/2016
,
the Sheraton Hotel in Doha
The Qatar Metabolic Institute is very pleased to present the 1st Annual Qatar Metabolic Institute Conference. The conference, co-organized by Hamad Medical Corporation (HMC) and Qatar Biomedical ...
Qatar Foundation Annual Research Conference 2016
22/03/2016
- 23/03/2016
,
Qatar National Convention Centre.
Qatar Foundation Research and Development’s flagship conference, builds upon nationwide efforts to advance Qatar's ambitious research agenda, and provides a unique platform to activate ...
From –Omics to Precision Medicine in Common Bone Disease, Are We There Yet?
28/02/2016
,
Dr. Omar Albagha; Cinema Theatre at HBKU Student Center
16/02/2016
,
Dr. Tariq Ahmed; Cinema Theatre at HBKU Student Center
